	SCH	9.391378168354773
¡°	5(s)-configuration ramipril	7.793073265595149
¡°	pharmaceutical drug ramipril	4.969745424534934
¡°	know ramipril	4.953345777171009
	ssssr stereoisomer	4.718683883039608
	six stereocenter	4.697116446481831
	three stereocenter	4.695704525672943
	two stereocenter	4.695689148848942
	Ramipril Ramipril	4.347435781413625
¡°	pharmaceutical compound ramipril	3.743078838555987
	rrsss	3.6244122679344852
	ssssr form	3.6166946591949536
	particular stereoisomer	3.461350964715121
	SSR stereoisomer	2.7260504310284
	various stereoisomer	2.3076228095440365
	four stereoisomer	2.30761445418699
	SSSSS 5(S stereoisomer	1.7040186532238137
	enalapril introduction	1.5528094635121275
	viper venom	1.4513173856834167
	5(s form	1.3543039952412967
	two orientation five stereocenter	1.3482933343842924
	captopril	1.2554682170355205
	bpp5a molecule	1.252804557985452
	SSS stereoisomer	1.1813667075630307
	Synthetic ACE inhibitor	1.1277136079574408
	Ramipril immediate predecessor	1.093949209136608
	Schering	0.8937529921201354
	ace inhibitor	0.8091633267502909
	ways.2	0.7261252878336844
	RRRRR	0.7261252878336844
	SSSSR	0.7261252878336844
	Enalapril	0.7261252878336844
	two bridgehead carbon	0.7154654214042
	Example	0.7025290802722285
	early ACE inhibitor	0.6645686441444657
	first synthetic ACE inhibitor	0.5559598099235549
	hypotensively effective amount	0.5449163233765294
	exactly two isomer	0.5053190059205857
	hypotensive composition	0.4937882624391343
	chirality center	0.493665557054769
	endo position	0.4839066291039184
	ring carbon atom	0.4669305064046641
	cis configuration relative	0.4645294879853939
	royalty payment	0.4587710599283742
	bicyclic ring system	0.4463976995468945
	Captopril	0.4188482647827046
	diastereomer	0.41866873271402344
	Angiotensin convert Enzyme inhibitor	0.3879544288248186
	sulfur atom	0.386223749605963
	five carbon atom	0.38621902171854544
	Brazilian Viper	0.3816578508721296
	leftmost mark carbon	0.35058441325357725
	enantiomer	0.33161072395542707
	convert Enzyme Inhibitors	0.331078257421913
	wherein hydrogen atom	0.31275006148846507
	filing	0.3103369178687651
	benzyl	0.2919756222362094
	r configuration	0.28786280655538504
	constituent atom	0.2469818644360786
	one tweak	0.2420417632225241
	two link five sided carbon ring	0.20918255229619792
	successive generation	0.20660340917905617
	H atom	0.20222123768090522
	carboxyl group	0.19684995361549787
	dash triangle	0.19465041482413958
	mercuric acetate oxidation step	0.19027000091506543
	Invalidity Opinion	0.1783321505077397
	purified formulation	0.170536521694346
	german precursor	0.16538388758142117
	r functional group	0.14828124280319138
	catalytic hydrogenation step	0.14610791925995265
	stereochemistry	0.1459878111181047
	fuse ring system	0.1440802923892498
	biochemical pathway	0.13773560611937077
	Virginia	0.1337788350109112
	two five sided ring	0.13079730385798852
	german application	0.11724926427909295
	second ring	0.11088374010218742
	physiologically acceptable salt	0.11071563446304365
	Merck scientist	0.0875066481500594
	write laboratory notebook	0.08444025493730854
	mixture therapeutic activity	0.08421098294298274
	single ring	0.0831680475428909
	blood vessel	0.07797815537323995
	pharmaceutically acceptable excipient therefor	0.07672610291130903
	GmbH	0.07282765571591757
	S configuration	0.06310383286338199
	methyl	0.06141803995103117
	standard chromatography technique	0.06037282549985684
	many complex organic molecule	0.05326079733983083
	vivo testing	0.04999738808703734
	Merck article	0.045926064105066965
	chemical diagram	0.04540374574681517
	one comparatively simple system	0.04515061233768357
	blood pressure medication	0.04448380584453559
	high blood pressure	0.042964760833673475
	mirror image	0.03963141157956333
	left side	0.03693567721771527
	active compound	0.03445493943600476
	willful infringement	0.03374552851421978
	Claimed Technology	0.029431909290397695
	left right hand	0.027914555872247664
	separate compound	0.026146852806639195
	first compound	0.025891798799360943
	exchange	0.02411851162451465
	therapeutic use	0.024108176388487706
	small genus	0.022618044323606357
	chemical composition	0.022286280490986042
	B. Development	0.020682699885195246
	priority	0.019453310721747233
	royalty bear license	0.015972304773291396
	three dimension	0.015451863647301346
	following structural formula	0.013891927703435605
	ANDA	0.012647568543238064
	week	0.011852725657011872
	i. BACKGROUND	0.009414991596769538
	structural modification	0.008275471090296924
	agent	0.007683376959955001
	interference	0.006760676974581589
	publish article	0.006585694923488194
	title	0.005926362828505936
	location	0.005756846620988182
	Abbreviated New Drug Application	0.005610068088123709
	pende continuation application	0.005027544405394642
	publish specification	0.004140848341640596
	production	0.0039177963121777735
	different functional group	0.00389946349044618
	Eastern District	0.0035183965321509227
	explicit finding	0.0032591262687055138
	May	0.003251597377903398
	November	0.002803687494173356
	February	0.0025741286067805474
	generic version	0.002409851656546726
	March	0.0022100417038685705
	October	0.0016414697946675002
	J.A.	0.0016305625273795234
	bench trial	0.0014764391547315943
	overall structure	0.0013543224831053147
	one distinction	0.0012225681629932212
	owner	0.0011566324735264035
	great detail	0.001143307638895405
	equivalent	0.0010416407394504043
	PTO	0.0008981283478110335
	asserted	0.0008544519195133228
	cross appeal	0.0006833605948248764
	practice	0.0003315893670215808
	primary subject matter	0.00025141529658450316
	method	0.00020674276977237837
	defendant	0.00019805672479122324
	Ltd.	0.00012790747523421975
	summary judgment	8.625829304447389e-05
	favor	7.90364738675479e-05
	example	7.374787560295943e-05
	background	6.967088117676966e-05
	remain issue	5.957930966154886e-05
	independent	4.697977423333296e-05
	U.S. Patent Trademark Office	4.493390275752473e-05
	holding	3.5808350262983914e-05
	final judgment	2.9212664943018755e-05
	language	2.1591137588680036e-05
	addition	1.906732539758479e-05
	different way	1.7729975851293296e-05
	purpose	1.7640744834180123e-05
	two one	1.6000605697009176e-05
	suit	1.4928682576352773e-05
	clear error	1.4022242882883614e-05
	opinion	9.535766312983593e-06
	U.S. application	2.2310373809423055e-06
	district court decision	1.918616541917492e-06
	district court finding	1.8825868485079501e-06
	Idaho	1.2588328460283702e-06
	light	1.1965954956466785e-06
	record	1.186469056416103e-06
	time	1.122844214871354e-06
	prior art reference	3.8043686480869464e-07
	infringement action	5.355809862433949e-08
	thus	2.029473718565815e-08
	fact	4.84150409871429e-09
	Court	0.0
	Appeals	0.0
	Inc.	0.0
